cohort - 4-year cumulative seizure risk decreased by 1.78%p and 1.46%p compared to other glucose-lowering drugs and SGLT2 inhibitors, respectively - Impact of blood glucose and weight reduction was minimal suggesting Semaglutides protective potential for brain health A large-scale, population-based study has shown that Semaglutide, widely used as a treatment for type 2 diabetes and obesity, can significantly lower the risk of adult-onset seizures
While research is still emerging, some studies suggest that oral supplementation can lead to improvements in skin tone and texture over time
We encourage you to track usage, note when vials are opened, and reach out if youre seeing any changes (cloudiness, reduced effect, etc.)
For adolescents, BMI criteria are based on age- and sex-specific percentiles rather than absolute values
They should be able to monitor your progress, address any side effects, and adjust your dosage as needed
A licensed provider should determine whether PT-141 is appropriate based on your full health history and current therapies